(Q38645273)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28770321%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

title

Metformin: clinical use in type 2 diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28770321%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1 reference

1 reference

type 2 diabetes

9 December 2023

Elizabeth Sanchez-Rangel

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28770321%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

author name string

Silvio E Inzucchi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28770321%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

publication date

2 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28770321%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28770321%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28770321%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28770321%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

page(s)

1586-1593

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28770321%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00125-017-4336-x

26 March 2020

exact match

0 references

cites work

Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Repurposing metformin: an old drug with new tricks in its binding pockets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

The mechanisms of action of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Improved glycaemic control by addition of glimepiride to metformin monotherapy in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Combination of insulin and metformin in the treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: a randomized, double-blind, non-inferiority trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Initial Combination Therapy With Canagliflozin Plus Metformin Versus Each Component as Monotherapy for Drug-Naïve Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Empagliflozin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Linagliptin and Metformin: A 24-Week Randomized, Double-Blind, Parallel-Group Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Comparison of chlorpropamide and metformin treatment on weight and blood-glucose response of uncontrolled obese diabetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Metformin: effects on cardiovascular risk factors in patients with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Metformin and digestive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

An overview of metformin in the treatment of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Metformin and the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Metformin-associated lactic acidosis: Current perspectives on causes and risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Metformin-associated lactic acidosis: a rare or very rare clinical entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Metformin in patients with type 2 diabetes and kidney disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Citizen Petition to the US Food and Drug Administration to Change Prescribing Guidelines: The Metformin Experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Metformin: New Preparations and Nonglycemic Benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Efficacy, tolerability, and safety of a novel once-daily extended-release metformin in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline From the American College of Physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Shifting Paradigms in the Medical Management of Type 2 Diabetes: Reflections on Recent Cardiovascular Outcome Trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4336-X

Management of non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28770321

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Efficacy and tolerability of vildagliptin vs. pioglitazone when added to metformin: a 24-week, randomized, double-blind study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28770321

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: a retrospective cohort study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28770321